We report four near-complete genome sequences of vesicular stomatitis virus (VSV) Indiana obtained with Sanger and Illumina next-generation sequencing, namely, laboratory strains HR (heat resistant) and T1026R1 and isolates 22-20 and 22-25. Previously, only the M gene of these viruses had been sequenced, and these sequences were not deposited in GenBank.
ABSTRACT
We report four near-complete genome sequences of vesicular stomatitis virus (VSV) Indiana obtained with Sanger and Illumina next-generation sequencing, namely, laboratory strains HR (heat resistant) and T1026R1 and isolates 22-20 and 22-25. Previously, only the M gene of these viruses had been sequenced, and these sequences were not deposited in GenBank.
ANNOUNCEMENT
Vesicular stomatitis virus (VSV) is a member of the genus Vesiculovirus in the family Rhabdoviridae and has an ∼11-kb nonsegmented, negative-sense, single-stranded RNA genome that encodes the nucleoprotein (N), matrix (M), glycoprotein (G), large (L), and phosphoprotein (P) proteins (1). We report the near-complete genome sequences of VSV Indiana laboratory strains HR (heat resistant) (2, 3) and T1026R1 (4) and plaque isolates 22-20 and 22-25, derived from Indiana parent strain 22 (03/87-CR-B, number 22), which was originally isolated from an infected cow (5). HR encodes a wild-type (wt) M protein and is therefore a virus that suppresses interferon (IFN) and inhibits host transcription. T1026R1 encodes a M51R mutation in the M protein which abrogates these functions of M (6–8). The M genes of 22-20 and 22-25 were reported to be identical, even though these isolates are discordant for IFN production in chicken embryo cells (9, 10). To determine if another viral component regulates IFN suppression, we sequenced the majority of these four virus genomes.
Virus stocks were propagated in Vero cells at a multiplicity of infection of 0.0001. Once 80 to 90% of the cells exhibited a cytopathic effect, the supernatant was harvested, centrifuged at 4,000 × g, aliquoted, and stored at −80°C. At least two virus stocks of each strain were sequenced and found to be identical. Sanger sequencing was performed first, and Illumina sequencing confirmed these results. Sanger and Illumina sequences were aligned for each virus to generate a consensus genome. For Sanger sequencing, the total RNA was extracted from L929 cells at 4 h postinfection (RNAqueous-4-PCR kit, Ambion). Reverse transcription, PCR, product purification, and sequencing were performed as previously described (11). For Illumina MiSeq sequencing, RNA was extracted from 1 ml of virus stock (QIAamp UltraSens virus kit, Qiagen). RNA quality and concentration were determined (Bioanalyzer Agilent RNA 6000 NanoAssay), and a library was constructed (TruSeq Stranded mRNA sample preparation kit, Illumina). The samples were pooled, and the multiplexed samples produced an average of 207,990 paired-end reads per sample (2 × 151 read length). Files were demultiplexed (bcl2fastq version 2.19.0), and adapters and low-quality reads were removed (Trimmomatic version 0.36) (12). Processed, cleaned reads were mapped to the human reference genome (GRCh38+gencode28) with STAR version 2.6.0c (13). Unmapped reads were then assembled de novo with SPAdes version 3.11.1 (14).
Sanger and Illumina contigs were aligned to each other and mapped to the NCBI reference sequence (GenBank accession number NC_001560) with CodonCode Aligner (CodonCode Corp.). Open reading frames (ORFs) were predicted with ORF Finder (Web version, NCBI) (15). Genome comparison of HR and T1026R1 confirmed the M51R mutation in the T1026R1 M protein and revealed a novel amino acid substitution in the T1026R1 G protein (S431A). Comparison of 22-25 and 22-20 revealed a previously unidentified D-to-G amino acid substitution at position 52 of the 22-20 M protein (D52G). A single amino acid change was identified in the 22-20 M protein, which suggests that this protein alone suppresses the IFN response. The genomes recovered ranged from 11,115 to 11,143 nucleotides in length, obtaining 99.59 to 99.84% of the genomes relative to the reference sequence. The missing nucleotides are located in noncoding regions at the ends of the genomes.
Data availability.
Genome sequences of 22-20, 22-25, T1026R21, and HR were deposited in GenBank (accession numbers MH919396, MH919397, MH919398, and MH919399, respectively). Raw Illumina reads were submitted to the Sequence Read Archive (BioProject number PRJNA508804).
ACKNOWLEDGMENTS
We thank Jean Lucas-Lenard for generously providing the HR and T1026R1 viruses and Luis L. Rodriquez for isolating the parent strain 22 and providing primer sequences. We are also grateful to Philip I. Marcus, who plaque purified and generously provided the 22-20 and 22-25 virus isolates. We also thank the University of Rochester Genomics Research Center (URGRC) for the library preparation, next-generation sequencing, data processing through de novo assembly, and technical support.
This work was supported by NIH grant R15 A1058969, the Thomas H. Gosnell School of Life Sciences, and the College of Science at Rochester Institute of Technology.
REFERENCES
- 1.Wagner RR, Rose JK. 1996. Rhabdoviridae: the viruses and their replication, p 561-573. In Fields BN, Knipe DM, Howley PM (ed), Fundamental virology, 3rd ed. Lippincott-Raven, Philadelphia, PA. [Google Scholar]
- 2.Marcus PI, Sekellick MJ. 1987. Interferon induction by viruses. XV. Biological characteristics of interferon induction-suppressing particles of vesicular stomatitis virus. J Interferon Res 7:269–284. doi: 10.1089/jir.1987.7.269. [DOI] [PubMed] [Google Scholar]
- 3.Wagner RR, Huang AS. 1966. Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology 28:1–10. doi: 10.1016/0042-6822(66)90300-X. [DOI] [PubMed] [Google Scholar]
- 4.Stanners CP, Francoeur AM, Lam T. 1977. Analysis of VSV mutant with attenuated cytopathogenicity: mutation in viral function, P, for inhibition of protein synthesis. Cell 11:273–281. doi: 10.1016/0092-8674(77)90044-7. [DOI] [PubMed] [Google Scholar]
- 5.Marcus PI, Sekellick MJ, Nichol ST. 1992. Interferon induction by viruses. XXI. Vesicular stomatitis virus: interferon inducibility as a phylogenetic marker. J Interferon Res 12:297–305. doi: 10.1089/jir.1992.12.297. [DOI] [PubMed] [Google Scholar]
- 6.Ferran MC, Lucas-Lenard JM. 1997. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol 71:371–377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Black BL, Rhodes RB, McKenzie M, Lyles DS. 1993. The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly. J Virol 67:4814–4821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Petersen JM, Her L-S, Varvel V, Lund E, Dahlberg JE. 2000. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol 20:8590–8601. doi: 10.1128/MCB.20.22.8590-8601.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Marcus PI, Sekellick MJ. 1994. Interferon induction: regulation by both virus and cell. Hokkaido Igaku Zasshi 69:1320–1331. [PubMed] [Google Scholar]
- 10.Marcus PI, Sekellick MJ, Spiropoulou CF, Nichol ST. 1993. Interferon induction by viruses. XXII. Vesicular stomatitis virus-Indiana: M-protein and leader RNA do not regulate interferon induction in chicken embryo cells. J Interferon Res 13:413–418. doi: 10.1089/jir.1993.13.413. [DOI] [PubMed] [Google Scholar]
- 11.Rodriguez LL, Pauszek SJ, Bunch TA, Schumann KR. 2002. Full-length genome analysis of natural isolates of vesicular stomatitis virus (Indiana 1 serotype) from North, Central and South America. J Gen Virol 83:2475–2483. doi: 10.1099/0022-1317-83-10-2475. [DOI] [PubMed] [Google Scholar]
- 12.Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. doi: 10.1093/bioinformatics/btu170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. doi: 10.1093/bioinformatics/bts635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wheeler DL, Church DM, Federhen S, Lash AE, Madden TL, Pontius JU, Schuler GD, Schriml LM, Sequeira E, Tatusova TA, Wagner L. 2003. Database resources of the National Center for Biotechnology. Nucleic Acids Res 31:28–33. doi: 10.1093/nar/gkg033. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Genome sequences of 22-20, 22-25, T1026R21, and HR were deposited in GenBank (accession numbers MH919396, MH919397, MH919398, and MH919399, respectively). Raw Illumina reads were submitted to the Sequence Read Archive (BioProject number PRJNA508804).